AltaRex: Clinical Trials

2 trials sponsored by AltaRex, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 unknown. 2 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 22Unknown 2

Follow AltaRex: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Monoclonal Antibody Therapy in Treating Patients With Ovarian, Fallopian Tube, or Peritoneal Cancer
oregovomab - Fallopian Tube Cancer, Ovarian Cancer
Phase 2UnknownAltaRex1021998-11-012013-11-06
Monoclonal Antibody Therapy in Treating Patients With Residual Disease From Stage III or Stage IV Ovarian Epithelial, Fallopian Tube, or Peritoneal Cancer Following Surgery and Chemotherapy
oregovomab - Fallopian Tube Cancer, Ovarian Cancer
Phase 2UnknownAltaRex4001998-04-012013-11-06

Conditions studied

Carcinoma, Ovarian Epithelial (2)  ·  Fallopian Tube Neoplasms (2)  ·  Ovarian Neoplasms (2)

Interventions

oregovomab (2)

Countries

Canada (2)  ·  United States (2)

Top investigators

Jonathan S. Berek, MD (1)  ·  Michael A. Bookman, MD (1)